To access this element change to forms mode OFF
Grant Award View - GA187317
Safety and Tolerability of AZD6482 in Reperfusion for Stroke (STARS)
GA ID:
GA187317
Agency:
Department of Health and Aged Care
Approval Date:
11-Jun-2021
Publish Date:
30-Aug-2021
Category:
Health and Medical Research
Grant Term:
11-Jun-2021 to 31-May-2024
Value (AUD):
$2,706,533.13
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DoHAC 20/21 1.1 Health Policy Research and Analysis
Grant Program:
MRFF_2020_Cardiovascular_Health_Mission
Grant Activity:
Safety and Tolerability of AZD6482 in Reperfusion for Stroke (STARS)
Purpose:
Stroke is a leading cause of death/disability worldwide. Identification of novel drugs that can improve clot lysis without causing bleeding would represent a major advance in stroke treatment. The Safety and Tolerability of AZD6482 in Reperfusion for Stroke (STARS) study - describes a Phase 2a, dose escalation study evaluating safety/tolerability of a novel anti-clotting drug (AZD6482) with promising preclinical safety/efficacy data, in adults with acute ischaemic stroke.
GO ID:
GO Title:
MRFF – Cardiovascular Health Mission – 2020 Cardiovascular Health Grant Opportunity
Internal Reference ID:
MRF2007344
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Sydney
Recipient ABN:
15 211 513 464
Grant Recipient Location
Suburb:
Camperdown
Town/City:
Camperdown
Postcode:
2050
State/Territory:
NSW
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
NSW
Postcode:
Country:
AUSTRALIA